What's in Beijing Suncadia Pharmaceuticals Co., Ltd's pipeline?

Beijing Suncadia Pharmaceuticals Co., Ltd has 7 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 2 in Phase 2, 3 in Phase 1.

Which companies overlap with Beijing Suncadia Pharmaceuticals Co., Ltd's portfolio?

Top competitors by shared drug class: Innovent Biologics (Suzhou) Co. Ltd., Assistance Publique - Hôpitaux de Paris, Bio-Thera Solutions, Boston Scientific Corporation, Sanofi.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/beijing-suncadia-pharmaceuticals-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Beijing Suncadia Pharmaceuticals Co., Ltd — Portfolio Competitive Intelligence Brief

Beijing Suncadia Pharmaceuticals Co., Ltd pipeline: 0 marketed, 0 filed, 2 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 2 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
SHR-2004 injection	SHR-2004 injection	phase 3	PD-1 inhibitor	PD-1	Oncology
SHR-1918 Injection	SHR-1918 Injection	phase 3	Bispecific antibody; PD-1/TGF-β inhibitor	PD-1 and TGF-β	Oncology

Therapeutic area mix

Oncology · 2
Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Innovent Biologics (Suzhou) Co. Ltd. · 2 shared drug classes
Assistance Publique - Hôpitaux de Paris · 2 shared drug classes
Bio-Thera Solutions · 2 shared drug classes
Boston Scientific Corporation · 2 shared drug classes
Sanofi · 2 shared drug classes
Shanghai Hengrui Pharmaceutical Co., Ltd. · 2 shared drug classes
Amgen · 1 shared drug class
Akeso · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Beijing Suncadia Pharmaceuticals Co., Ltd:

Cite this brief

Drug Landscape (2026). Beijing Suncadia Pharmaceuticals Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beijing-suncadia-pharmaceuticals-co-ltd. Accessed 2026-05-16.